- Home
- UNCY vs HYMC Comparison
UNCY vs HYMC Comparison
Compare UNCY & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- HYMC
- Stock Information
- Founded
- UNCY 2016
- HYMC N/A
- Country
- UNCY United States
- HYMC United States
- Employees
- UNCY N/A
- HYMC N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- HYMC Precious Metals
- Sector
- UNCY Health Care
- HYMC Basic Materials
- Exchange
- UNCY Nasdaq
- HYMC Nasdaq
- Market Cap
- UNCY 71.8M
- HYMC N/A
- IPO Year
- UNCY 2021
- HYMC N/A
- Fundamental
- Price
- UNCY $0.60
- HYMC $3.67
- Analyst Decision
- UNCY Strong Buy
- HYMC
- Analyst Count
- UNCY 2
- HYMC 0
- Target Price
- UNCY $5.25
- HYMC N/A
- AVG Volume (30 Days)
- UNCY 1.2M
- HYMC 282.4K
- Earning Date
- UNCY 05-12-2025
- HYMC 05-06-2025
- Dividend Yield
- UNCY N/A
- HYMC N/A
- EPS Growth
- UNCY N/A
- HYMC N/A
- EPS
- UNCY N/A
- HYMC N/A
- Revenue
- UNCY N/A
- HYMC N/A
- Revenue This Year
- UNCY N/A
- HYMC N/A
- Revenue Next Year
- UNCY $1,677.16
- HYMC N/A
- P/E Ratio
- UNCY N/A
- HYMC N/A
- Revenue Growth
- UNCY N/A
- HYMC N/A
- 52 Week Low
- UNCY $0.20
- HYMC $1.95
- 52 Week High
- UNCY $1.29
- HYMC $4.02
- Technical
- Relative Strength Index (RSI)
- UNCY 54.18
- HYMC 64.48
- Support Level
- UNCY $0.45
- HYMC $2.43
- Resistance Level
- UNCY $0.63
- HYMC $2.95
- Average True Range (ATR)
- UNCY 0.06
- HYMC 0.33
- MACD
- UNCY 0.01
- HYMC 0.06
- Stochastic Oscillator
- UNCY 78.95
- HYMC 91.95
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.